chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Brain natriuretic peptide increased, COVID-19, Cardiac failure, Cardiac failure acute, Cardiac failure congestive
Clinical narrative: COVID+ -no date listed.  Vaccination status - pfizer x3 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/30/2022 Discharge Date: Nov 4, 2022   Active Hospital Problems   Diagnosis Date Noted POA ? Respiratory failure (HCC) 10/30/2022 Unknown ? H/O splenectomy 10/30/2022 Unknown ? COPD with acute exacerbation (HCC) 09/21/2022 Yes ? OSA on CPAP 02/19/2020 Yes ? Chronic diastolic congestive heart failure (HCC) 12/07/2018 Yes ? Lung nodules    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Respiratory failure (HCC) [J96.90] Chronic obstructive pulmonary disease with acute exacerbation (HCC) [J44.1] Chronic respiratory failure with hypoxia and hypercapnia (HCC) [J96.11, J96.12] Acute on chronic congestive heart failure, unspecified heart failure type (HCC) [I50.9] Acute on chronic respiratory failure with hypoxia (HCC) [J96.21]   HOSPITAL COURSE: 78-year-old patient in our facility 10/4-10/14 with respiratory failure requiring intubation, COVID, CHF exacerbation, COPD exacerbation.  Intubated 10/4-10/5.  Completed five days Remdesivir 10/8.  Received steroids during the hospitalization.  After extubation she was very resistant to wearing BiPAP. Patient had not been wearing her CPAP or Bipap since she got home because it hurts her neck.  She got confused and was brought to the ER. She was awake and talking on arrival but became progressively more somnolent.  She was given Lasix, nebulizer and BiPAP but mental status worsened.  ABG showed pCO2 > 110 with pH 7.32.  She was intubated and started on propofol drip. She was admitted to the ICU intubated. She was able to be extubated on 10/31. She continued on nebulizers and steroids. She did continue to test + for COVID-19 but had not active symptoms, this was felt to all be related to COPD and hypercarbia from lack of OSA treatment. She continued to improve and was breathing well on her home O2. Her O2 was kept between 89-93% due to her severe COPD. She was fitted with nasal pillows for her Bipap and improved with this. She tolerated this well. PT/OT recommended subacute rehab which the patient agreed. Patient was then discharged to SAR in stable condition. She MUST wear her bipap or will be high risk for re-admission. She will continue on a long steroid taper. Patient discharged to rehab in stable condition.  PT d/c'd to Skilled nursing & rehab facility (rehab 11/4/22-11/12/22)
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest X-ray abnormal, Chronic obstructive pulmonary disease, Condition aggravated, Cough, Dyspnoea
Clinical narrative: COVID+ -no date listed.  Vaccination status - pfizer x3 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/30/2022 Discharge Date: Nov 4, 2022   Active Hospital Problems   Diagnosis Date Noted POA ? Respiratory failure (HCC) 10/30/2022 Unknown ? H/O splenectomy 10/30/2022 Unknown ? COPD with acute exacerbation (HCC) 09/21/2022 Yes ? OSA on CPAP 02/19/2020 Yes ? Chronic diastolic congestive heart failure (HCC) 12/07/2018 Yes ? Lung nodules    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Respiratory failure (HCC) [J96.90] Chronic obstructive pulmonary disease with acute exacerbation (HCC) [J44.1] Chronic respiratory failure with hypoxia and hypercapnia (HCC) [J96.11, J96.12] Acute on chronic congestive heart failure, unspecified heart failure type (HCC) [I50.9] Acute on chronic respiratory failure with hypoxia (HCC) [J96.21]   HOSPITAL COURSE: 78-year-old patient in our facility 10/4-10/14 with respiratory failure requiring intubation, COVID, CHF exacerbation, COPD exacerbation.  Intubated 10/4-10/5.  Completed five days Remdesivir 10/8.  Received steroids during the hospitalization.  After extubation she was very resistant to wearing BiPAP. Patient had not been wearing her CPAP or Bipap since she got home because it hurts her neck.  She got confused and was brought to the ER. She was awake and talking on arrival but became progressively more somnolent.  She was given Lasix, nebulizer and BiPAP but mental status worsened.  ABG showed pCO2 > 110 with pH 7.32.  She was intubated and started on propofol drip. She was admitted to the ICU intubated. She was able to be extubated on 10/31. She continued on nebulizers and steroids. She did continue to test + for COVID-19 but had not active symptoms, this was felt to all be related to COPD and hypercarbia from lack of OSA treatment. She continued to improve and was breathing well on her home O2. Her O2 was kept between 89-93% due to her severe COPD. She was fitted with nasal pillows for her Bipap and improved with this. She tolerated this well. PT/OT recommended subacute rehab which the patient agreed. Patient was then discharged to SAR in stable condition. She MUST wear her bipap or will be high risk for re-admission. She will continue on a long steroid taper. Patient discharged to rehab in stable condition.  PT d/c'd to Skilled nursing & rehab facility (rehab 11/4/22-11/12/22)
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Echocardiogram, Ejection fraction normal, Endotracheal intubation, Fatigue, Fraction of inspired oxygen
Clinical narrative: COVID+ -no date listed.  Vaccination status - pfizer x3 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/30/2022 Discharge Date: Nov 4, 2022   Active Hospital Problems   Diagnosis Date Noted POA ? Respiratory failure (HCC) 10/30/2022 Unknown ? H/O splenectomy 10/30/2022 Unknown ? COPD with acute exacerbation (HCC) 09/21/2022 Yes ? OSA on CPAP 02/19/2020 Yes ? Chronic diastolic congestive heart failure (HCC) 12/07/2018 Yes ? Lung nodules    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Respiratory failure (HCC) [J96.90] Chronic obstructive pulmonary disease with acute exacerbation (HCC) [J44.1] Chronic respiratory failure with hypoxia and hypercapnia (HCC) [J96.11, J96.12] Acute on chronic congestive heart failure, unspecified heart failure type (HCC) [I50.9] Acute on chronic respiratory failure with hypoxia (HCC) [J96.21]   HOSPITAL COURSE: 78-year-old patient in our facility 10/4-10/14 with respiratory failure requiring intubation, COVID, CHF exacerbation, COPD exacerbation.  Intubated 10/4-10/5.  Completed five days Remdesivir 10/8.  Received steroids during the hospitalization.  After extubation she was very resistant to wearing BiPAP. Patient had not been wearing her CPAP or Bipap since she got home because it hurts her neck.  She got confused and was brought to the ER. She was awake and talking on arrival but became progressively more somnolent.  She was given Lasix, nebulizer and BiPAP but mental status worsened.  ABG showed pCO2 > 110 with pH 7.32.  She was intubated and started on propofol drip. She was admitted to the ICU intubated. She was able to be extubated on 10/31. She continued on nebulizers and steroids. She did continue to test + for COVID-19 but had not active symptoms, this was felt to all be related to COPD and hypercarbia from lack of OSA treatment. She continued to improve and was breathing well on her home O2. Her O2 was kept between 89-93% due to her severe COPD. She was fitted with nasal pillows for her Bipap and improved with this. She tolerated this well. PT/OT recommended subacute rehab which the patient agreed. Patient was then discharged to SAR in stable condition. She MUST wear her bipap or will be high risk for re-admission. She will continue on a long steroid taper. Patient discharged to rehab in stable condition.  PT d/c'd to Skilled nursing & rehab facility (rehab 11/4/22-11/12/22)
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypertension, Influenza virus test negative, Intensive care, Laboratory test, Left ventricular failure
Clinical narrative: COVID+ -no date listed.  Vaccination status - pfizer x3 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/30/2022 Discharge Date: Nov 4, 2022   Active Hospital Problems   Diagnosis Date Noted POA ? Respiratory failure (HCC) 10/30/2022 Unknown ? H/O splenectomy 10/30/2022 Unknown ? COPD with acute exacerbation (HCC) 09/21/2022 Yes ? OSA on CPAP 02/19/2020 Yes ? Chronic diastolic congestive heart failure (HCC) 12/07/2018 Yes ? Lung nodules    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Respiratory failure (HCC) [J96.90] Chronic obstructive pulmonary disease with acute exacerbation (HCC) [J44.1] Chronic respiratory failure with hypoxia and hypercapnia (HCC) [J96.11, J96.12] Acute on chronic congestive heart failure, unspecified heart failure type (HCC) [I50.9] Acute on chronic respiratory failure with hypoxia (HCC) [J96.21]   HOSPITAL COURSE: 78-year-old patient in our facility 10/4-10/14 with respiratory failure requiring intubation, COVID, CHF exacerbation, COPD exacerbation.  Intubated 10/4-10/5.  Completed five days Remdesivir 10/8.  Received steroids during the hospitalization.  After extubation she was very resistant to wearing BiPAP. Patient had not been wearing her CPAP or Bipap since she got home because it hurts her neck.  She got confused and was brought to the ER. She was awake and talking on arrival but became progressively more somnolent.  She was given Lasix, nebulizer and BiPAP but mental status worsened.  ABG showed pCO2 > 110 with pH 7.32.  She was intubated and started on propofol drip. She was admitted to the ICU intubated. She was able to be extubated on 10/31. She continued on nebulizers and steroids. She did continue to test + for COVID-19 but had not active symptoms, this was felt to all be related to COPD and hypercarbia from lack of OSA treatment. She continued to improve and was breathing well on her home O2. Her O2 was kept between 89-93% due to her severe COPD. She was fitted with nasal pillows for her Bipap and improved with this. She tolerated this well. PT/OT recommended subacute rehab which the patient agreed. Patient was then discharged to SAR in stable condition. She MUST wear her bipap or will be high risk for re-admission. She will continue on a long steroid taper. Patient discharged to rehab in stable condition.  PT d/c'd to Skilled nursing & rehab facility (rehab 11/4/22-11/12/22)
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Leukocytosis, Nasal congestion, Obstructive sleep apnoea syndrome, Oedema peripheral, Oxygen saturation decreased
Clinical narrative: COVID+ -no date listed.  Vaccination status - pfizer x3 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/30/2022 Discharge Date: Nov 4, 2022   Active Hospital Problems   Diagnosis Date Noted POA ? Respiratory failure (HCC) 10/30/2022 Unknown ? H/O splenectomy 10/30/2022 Unknown ? COPD with acute exacerbation (HCC) 09/21/2022 Yes ? OSA on CPAP 02/19/2020 Yes ? Chronic diastolic congestive heart failure (HCC) 12/07/2018 Yes ? Lung nodules    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Respiratory failure (HCC) [J96.90] Chronic obstructive pulmonary disease with acute exacerbation (HCC) [J44.1] Chronic respiratory failure with hypoxia and hypercapnia (HCC) [J96.11, J96.12] Acute on chronic congestive heart failure, unspecified heart failure type (HCC) [I50.9] Acute on chronic respiratory failure with hypoxia (HCC) [J96.21]   HOSPITAL COURSE: 78-year-old patient in our facility 10/4-10/14 with respiratory failure requiring intubation, COVID, CHF exacerbation, COPD exacerbation.  Intubated 10/4-10/5.  Completed five days Remdesivir 10/8.  Received steroids during the hospitalization.  After extubation she was very resistant to wearing BiPAP. Patient had not been wearing her CPAP or Bipap since she got home because it hurts her neck.  She got confused and was brought to the ER. She was awake and talking on arrival but became progressively more somnolent.  She was given Lasix, nebulizer and BiPAP but mental status worsened.  ABG showed pCO2 > 110 with pH 7.32.  She was intubated and started on propofol drip. She was admitted to the ICU intubated. She was able to be extubated on 10/31. She continued on nebulizers and steroids. She did continue to test + for COVID-19 but had not active symptoms, this was felt to all be related to COPD and hypercarbia from lack of OSA treatment. She continued to improve and was breathing well on her home O2. Her O2 was kept between 89-93% due to her severe COPD. She was fitted with nasal pillows for her Bipap and improved with this. She tolerated this well. PT/OT recommended subacute rehab which the patient agreed. Patient was then discharged to SAR in stable condition. She MUST wear her bipap or will be high risk for re-admission. She will continue on a long steroid taper. Patient discharged to rehab in stable condition.  PT d/c'd to Skilled nursing & rehab facility (rehab 11/4/22-11/12/22)
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: PCO2 increased, Peripheral swelling, Pleural effusion, Positive airway pressure therapy, Productive cough
Clinical narrative: COVID+ -no date listed.  Vaccination status - pfizer x3 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/30/2022 Discharge Date: Nov 4, 2022   Active Hospital Problems   Diagnosis Date Noted POA ? Respiratory failure (HCC) 10/30/2022 Unknown ? H/O splenectomy 10/30/2022 Unknown ? COPD with acute exacerbation (HCC) 09/21/2022 Yes ? OSA on CPAP 02/19/2020 Yes ? Chronic diastolic congestive heart failure (HCC) 12/07/2018 Yes ? Lung nodules    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Respiratory failure (HCC) [J96.90] Chronic obstructive pulmonary disease with acute exacerbation (HCC) [J44.1] Chronic respiratory failure with hypoxia and hypercapnia (HCC) [J96.11, J96.12] Acute on chronic congestive heart failure, unspecified heart failure type (HCC) [I50.9] Acute on chronic respiratory failure with hypoxia (HCC) [J96.21]   HOSPITAL COURSE: 78-year-old patient in our facility 10/4-10/14 with respiratory failure requiring intubation, COVID, CHF exacerbation, COPD exacerbation.  Intubated 10/4-10/5.  Completed five days Remdesivir 10/8.  Received steroids during the hospitalization.  After extubation she was very resistant to wearing BiPAP. Patient had not been wearing her CPAP or Bipap since she got home because it hurts her neck.  She got confused and was brought to the ER. She was awake and talking on arrival but became progressively more somnolent.  She was given Lasix, nebulizer and BiPAP but mental status worsened.  ABG showed pCO2 > 110 with pH 7.32.  She was intubated and started on propofol drip. She was admitted to the ICU intubated. She was able to be extubated on 10/31. She continued on nebulizers and steroids. She did continue to test + for COVID-19 but had not active symptoms, this was felt to all be related to COPD and hypercarbia from lack of OSA treatment. She continued to improve and was breathing well on her home O2. Her O2 was kept between 89-93% due to her severe COPD. She was fitted with nasal pillows for her Bipap and improved with this. She tolerated this well. PT/OT recommended subacute rehab which the patient agreed. Patient was then discharged to SAR in stable condition. She MUST wear her bipap or will be high risk for re-admission. She will continue on a long steroid taper. Patient discharged to rehab in stable condition.  PT d/c'd to Skilled nursing & rehab facility (rehab 11/4/22-11/12/22)
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pulmonary function test abnormal, Pulmonary oedema, Respiratory acidosis, Respiratory failure, Respiratory syncytial virus test negative
Clinical narrative: COVID+ -no date listed.  Vaccination status - pfizer x3 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/30/2022 Discharge Date: Nov 4, 2022   Active Hospital Problems   Diagnosis Date Noted POA ? Respiratory failure (HCC) 10/30/2022 Unknown ? H/O splenectomy 10/30/2022 Unknown ? COPD with acute exacerbation (HCC) 09/21/2022 Yes ? OSA on CPAP 02/19/2020 Yes ? Chronic diastolic congestive heart failure (HCC) 12/07/2018 Yes ? Lung nodules    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Respiratory failure (HCC) [J96.90] Chronic obstructive pulmonary disease with acute exacerbation (HCC) [J44.1] Chronic respiratory failure with hypoxia and hypercapnia (HCC) [J96.11, J96.12] Acute on chronic congestive heart failure, unspecified heart failure type (HCC) [I50.9] Acute on chronic respiratory failure with hypoxia (HCC) [J96.21]   HOSPITAL COURSE: 78-year-old patient in our facility 10/4-10/14 with respiratory failure requiring intubation, COVID, CHF exacerbation, COPD exacerbation.  Intubated 10/4-10/5.  Completed five days Remdesivir 10/8.  Received steroids during the hospitalization.  After extubation she was very resistant to wearing BiPAP. Patient had not been wearing her CPAP or Bipap since she got home because it hurts her neck.  She got confused and was brought to the ER. She was awake and talking on arrival but became progressively more somnolent.  She was given Lasix, nebulizer and BiPAP but mental status worsened.  ABG showed pCO2 > 110 with pH 7.32.  She was intubated and started on propofol drip. She was admitted to the ICU intubated. She was able to be extubated on 10/31. She continued on nebulizers and steroids. She did continue to test + for COVID-19 but had not active symptoms, this was felt to all be related to COPD and hypercarbia from lack of OSA treatment. She continued to improve and was breathing well on her home O2. Her O2 was kept between 89-93% due to her severe COPD. She was fitted with nasal pillows for her Bipap and improved with this. She tolerated this well. PT/OT recommended subacute rehab which the patient agreed. Patient was then discharged to SAR in stable condition. She MUST wear her bipap or will be high risk for re-admission. She will continue on a long steroid taper. Patient discharged to rehab in stable condition.  PT d/c'd to Skilled nursing & rehab facility (rehab 11/4/22-11/12/22)
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test negative, SARS-CoV-2 test positive, Tachycardia, Tachypnoea, Therapeutic product ineffective
Clinical narrative: COVID+ -no date listed.  Vaccination status - pfizer x3 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/30/2022 Discharge Date: Nov 4, 2022   Active Hospital Problems   Diagnosis Date Noted POA ? Respiratory failure (HCC) 10/30/2022 Unknown ? H/O splenectomy 10/30/2022 Unknown ? COPD with acute exacerbation (HCC) 09/21/2022 Yes ? OSA on CPAP 02/19/2020 Yes ? Chronic diastolic congestive heart failure (HCC) 12/07/2018 Yes ? Lung nodules    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Respiratory failure (HCC) [J96.90] Chronic obstructive pulmonary disease with acute exacerbation (HCC) [J44.1] Chronic respiratory failure with hypoxia and hypercapnia (HCC) [J96.11, J96.12] Acute on chronic congestive heart failure, unspecified heart failure type (HCC) [I50.9] Acute on chronic respiratory failure with hypoxia (HCC) [J96.21]   HOSPITAL COURSE: 78-year-old patient in our facility 10/4-10/14 with respiratory failure requiring intubation, COVID, CHF exacerbation, COPD exacerbation.  Intubated 10/4-10/5.  Completed five days Remdesivir 10/8.  Received steroids during the hospitalization.  After extubation she was very resistant to wearing BiPAP. Patient had not been wearing her CPAP or Bipap since she got home because it hurts her neck.  She got confused and was brought to the ER. She was awake and talking on arrival but became progressively more somnolent.  She was given Lasix, nebulizer and BiPAP but mental status worsened.  ABG showed pCO2 > 110 with pH 7.32.  She was intubated and started on propofol drip. She was admitted to the ICU intubated. She was able to be extubated on 10/31. She continued on nebulizers and steroids. She did continue to test + for COVID-19 but had not active symptoms, this was felt to all be related to COPD and hypercarbia from lack of OSA treatment. She continued to improve and was breathing well on her home O2. Her O2 was kept between 89-93% due to her severe COPD. She was fitted with nasal pillows for her Bipap and improved with this. She tolerated this well. PT/OT recommended subacute rehab which the patient agreed. Patient was then discharged to SAR in stable condition. She MUST wear her bipap or will be high risk for re-admission. She will continue on a long steroid taper. Patient discharged to rehab in stable condition.  PT d/c'd to Skilled nursing & rehab facility (rehab 11/4/22-11/12/22)
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tremor, White blood cell count increased
Clinical narrative: COVID+ -no date listed.  Vaccination status - pfizer x3 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 10/30/2022 Discharge Date: Nov 4, 2022   Active Hospital Problems   Diagnosis Date Noted POA ? Respiratory failure (HCC) 10/30/2022 Unknown ? H/O splenectomy 10/30/2022 Unknown ? COPD with acute exacerbation (HCC) 09/21/2022 Yes ? OSA on CPAP 02/19/2020 Yes ? Chronic diastolic congestive heart failure (HCC) 12/07/2018 Yes ? Lung nodules    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Respiratory failure (HCC) [J96.90] Chronic obstructive pulmonary disease with acute exacerbation (HCC) [J44.1] Chronic respiratory failure with hypoxia and hypercapnia (HCC) [J96.11, J96.12] Acute on chronic congestive heart failure, unspecified heart failure type (HCC) [I50.9] Acute on chronic respiratory failure with hypoxia (HCC) [J96.21]   HOSPITAL COURSE: 78-year-old patient in our facility 10/4-10/14 with respiratory failure requiring intubation, COVID, CHF exacerbation, COPD exacerbation.  Intubated 10/4-10/5.  Completed five days Remdesivir 10/8.  Received steroids during the hospitalization.  After extubation she was very resistant to wearing BiPAP. Patient had not been wearing her CPAP or Bipap since she got home because it hurts her neck.  She got confused and was brought to the ER. She was awake and talking on arrival but became progressively more somnolent.  She was given Lasix, nebulizer and BiPAP but mental status worsened.  ABG showed pCO2 > 110 with pH 7.32.  She was intubated and started on propofol drip. She was admitted to the ICU intubated. She was able to be extubated on 10/31. She continued on nebulizers and steroids. She did continue to test + for COVID-19 but had not active symptoms, this was felt to all be related to COPD and hypercarbia from lack of OSA treatment. She continued to improve and was breathing well on her home O2. Her O2 was kept between 89-93% due to her severe COPD. She was fitted with nasal pillows for her Bipap and improved with this. She tolerated this well. PT/OT recommended subacute rehab which the patient agreed. Patient was then discharged to SAR in stable condition. She MUST wear her bipap or will be high risk for re-admission. She will continue on a long steroid taper. Patient discharged to rehab in stable condition.  PT d/c'd to Skilled nursing & rehab facility (rehab 11/4/22-11/12/22)
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19-2
Symptoms: Back pain, Body height, Gait disturbance, Illness, Weight
Clinical narrative: Patient reports she got sick five days after receiving the vaccine and still does not feel well. She reports back and side pain and difficulty walking. She says she went to the ER and was checked out and sent home. She contacted pfizer to report this. Pharmacy staff recommended she follow up with primary care as well.
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19-2
Symptoms: Back pain, Flank pain, Gait disturbance, Malaise
Clinical narrative: Patient reports she got sick five days after receiving the vaccine and still does not feel well. She reports back and side pain and difficulty walking. She says she went to the ER and was checked out and sent home. She contacted pfizer to report this. Pharmacy staff recommended she follow up with primary care as well.
Age: 4.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Adverse reaction, Cerebral disorder, Computerised tomogram, Electroencephalogram, Lumbar puncture
Clinical narrative: Had covid vaccine #2 11/3/2022 The morning of 11/4, Patient was at day care and was acting sleepy; nurse started noticing things that "started to look like a seizure" and they ultimately called EMS. When EMS arrived, they gave him 1mg dose of ativan in the ambulance. Took him to our county hospital emergency room where he was intubated and stabilized.   In the ICU patient was monitored on LTM, and no seizure activity was appreciated. He was empirically started on ceftriaxone, vancomycin, and acyclovir. CSF culture was negative at time of transfer. On 11/5 an LP was performed, what results in normal cell counts and was negative for HSV so the acyclovir was discontinued. Patient was extubated on 11/5. His antibiotics were discontinued on 11/6 given normal cell count in his CSF, negative blood cultures, and reassuring clinical presentation. To rule out any intracranial process that could be contributing to his presentation, a head MRI was done on 11/5, which demonstrated ventriculomegaly and white matter changes without aqueductal stenosis. There were no indications for surgical intervention. Neurology was consulted and affirmed that the MRI findings were consistent with his underlying chronic conditions. They recommended diastat for a seizure rescue medication at home and an outpatient neurology follow up.   After being extubated on 11/5, Patient was advanced to a regular diet which he tolerated well.    Patient was admitted to the general pediatrics from 11/6-11/7.
Age: 4.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging, Nervous system disorder, Seizure like phenomena
Clinical narrative: Had covid vaccine #2 11/3/2022 The morning of 11/4, Patient was at day care and was acting sleepy; nurse started noticing things that "started to look like a seizure" and they ultimately called EMS. When EMS arrived, they gave him 1mg dose of ativan in the ambulance. Took him to our county hospital emergency room where he was intubated and stabilized.   In the ICU patient was monitored on LTM, and no seizure activity was appreciated. He was empirically started on ceftriaxone, vancomycin, and acyclovir. CSF culture was negative at time of transfer. On 11/5 an LP was performed, what results in normal cell counts and was negative for HSV so the acyclovir was discontinued. Patient was extubated on 11/5. His antibiotics were discontinued on 11/6 given normal cell count in his CSF, negative blood cultures, and reassuring clinical presentation. To rule out any intracranial process that could be contributing to his presentation, a head MRI was done on 11/5, which demonstrated ventriculomegaly and white matter changes without aqueductal stenosis. There were no indications for surgical intervention. Neurology was consulted and affirmed that the MRI findings were consistent with his underlying chronic conditions. They recommended diastat for a seizure rescue medication at home and an outpatient neurology follow up.   After being extubated on 11/5, Patient was advanced to a regular diet which he tolerated well.    Patient was admitted to the general pediatrics from 11/6-11/7.
Age: 4.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Adenovirus test positive, Blood calcium decreased, Blood chloride increased, Blood culture negative, Blood phosphorus
Clinical narrative: Had covid vaccine #2 11/3/2022 The morning of 11/4, Patient was at day care and was acting sleepy; nurse started noticing things that "started to look like a seizure" and they ultimately called EMS. When EMS arrived, they gave him 1mg dose of ativan in the ambulance. Took him to our county hospital emergency room where he was intubated and stabilized.   In the ICU patient was monitored on LTM, and no seizure activity was appreciated. He was empirically started on ceftriaxone, vancomycin, and acyclovir. CSF culture was negative at time of transfer. On 11/5 an LP was performed, what results in normal cell counts and was negative for HSV so the acyclovir was discontinued. Patient was extubated on 11/5. His antibiotics were discontinued on 11/6 given normal cell count in his CSF, negative blood cultures, and reassuring clinical presentation. To rule out any intracranial process that could be contributing to his presentation, a head MRI was done on 11/5, which demonstrated ventriculomegaly and white matter changes without aqueductal stenosis. There were no indications for surgical intervention. Neurology was consulted and affirmed that the MRI findings were consistent with his underlying chronic conditions. They recommended diastat for a seizure rescue medication at home and an outpatient neurology follow up.   After being extubated on 11/5, Patient was advanced to a regular diet which he tolerated well.    Patient was admitted to the general pediatrics from 11/6-11/7.
Age: 4.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood potassium decreased, CSF cell count normal, CSF culture negative, CSF protein, CSF red blood cell count positive
Clinical narrative: Had covid vaccine #2 11/3/2022 The morning of 11/4, Patient was at day care and was acting sleepy; nurse started noticing things that "started to look like a seizure" and they ultimately called EMS. When EMS arrived, they gave him 1mg dose of ativan in the ambulance. Took him to our county hospital emergency room where he was intubated and stabilized.   In the ICU patient was monitored on LTM, and no seizure activity was appreciated. He was empirically started on ceftriaxone, vancomycin, and acyclovir. CSF culture was negative at time of transfer. On 11/5 an LP was performed, what results in normal cell counts and was negative for HSV so the acyclovir was discontinued. Patient was extubated on 11/5. His antibiotics were discontinued on 11/6 given normal cell count in his CSF, negative blood cultures, and reassuring clinical presentation. To rule out any intracranial process that could be contributing to his presentation, a head MRI was done on 11/5, which demonstrated ventriculomegaly and white matter changes without aqueductal stenosis. There were no indications for surgical intervention. Neurology was consulted and affirmed that the MRI findings were consistent with his underlying chronic conditions. They recommended diastat for a seizure rescue medication at home and an outpatient neurology follow up.   After being extubated on 11/5, Patient was advanced to a regular diet which he tolerated well.    Patient was admitted to the general pediatrics from 11/6-11/7.
Age: 4.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cerebral ventricle dilatation, Computerised tomogram, Endotracheal intubation, Extubation, Herpes simplex test negative
Clinical narrative: Had covid vaccine #2 11/3/2022 The morning of 11/4, Patient was at day care and was acting sleepy; nurse started noticing things that "started to look like a seizure" and they ultimately called EMS. When EMS arrived, they gave him 1mg dose of ativan in the ambulance. Took him to our county hospital emergency room where he was intubated and stabilized.   In the ICU patient was monitored on LTM, and no seizure activity was appreciated. He was empirically started on ceftriaxone, vancomycin, and acyclovir. CSF culture was negative at time of transfer. On 11/5 an LP was performed, what results in normal cell counts and was negative for HSV so the acyclovir was discontinued. Patient was extubated on 11/5. His antibiotics were discontinued on 11/6 given normal cell count in his CSF, negative blood cultures, and reassuring clinical presentation. To rule out any intracranial process that could be contributing to his presentation, a head MRI was done on 11/5, which demonstrated ventriculomegaly and white matter changes without aqueductal stenosis. There were no indications for surgical intervention. Neurology was consulted and affirmed that the MRI findings were consistent with his underlying chronic conditions. They recommended diastat for a seizure rescue medication at home and an outpatient neurology follow up.   After being extubated on 11/5, Patient was advanced to a regular diet which he tolerated well.    Patient was admitted to the general pediatrics from 11/6-11/7.
Age: 4.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Human rhinovirus test positive, Intensive care, Magnetic resonance imaging head abnormal, Metabolic function test, Respiratory viral panel
Clinical narrative: Had covid vaccine #2 11/3/2022 The morning of 11/4, Patient was at day care and was acting sleepy; nurse started noticing things that "started to look like a seizure" and they ultimately called EMS. When EMS arrived, they gave him 1mg dose of ativan in the ambulance. Took him to our county hospital emergency room where he was intubated and stabilized.   In the ICU patient was monitored on LTM, and no seizure activity was appreciated. He was empirically started on ceftriaxone, vancomycin, and acyclovir. CSF culture was negative at time of transfer. On 11/5 an LP was performed, what results in normal cell counts and was negative for HSV so the acyclovir was discontinued. Patient was extubated on 11/5. His antibiotics were discontinued on 11/6 given normal cell count in his CSF, negative blood cultures, and reassuring clinical presentation. To rule out any intracranial process that could be contributing to his presentation, a head MRI was done on 11/5, which demonstrated ventriculomegaly and white matter changes without aqueductal stenosis. There were no indications for surgical intervention. Neurology was consulted and affirmed that the MRI findings were consistent with his underlying chronic conditions. They recommended diastat for a seizure rescue medication at home and an outpatient neurology follow up.   After being extubated on 11/5, Patient was advanced to a regular diet which he tolerated well.    Patient was admitted to the general pediatrics from 11/6-11/7.
Age: 4.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Seizure like phenomena, Somnolence, White matter lesion, X-ray
Clinical narrative: Had covid vaccine #2 11/3/2022 The morning of 11/4, Patient was at day care and was acting sleepy; nurse started noticing things that "started to look like a seizure" and they ultimately called EMS. When EMS arrived, they gave him 1mg dose of ativan in the ambulance. Took him to our county hospital emergency room where he was intubated and stabilized.   In the ICU patient was monitored on LTM, and no seizure activity was appreciated. He was empirically started on ceftriaxone, vancomycin, and acyclovir. CSF culture was negative at time of transfer. On 11/5 an LP was performed, what results in normal cell counts and was negative for HSV so the acyclovir was discontinued. Patient was extubated on 11/5. His antibiotics were discontinued on 11/6 given normal cell count in his CSF, negative blood cultures, and reassuring clinical presentation. To rule out any intracranial process that could be contributing to his presentation, a head MRI was done on 11/5, which demonstrated ventriculomegaly and white matter changes without aqueductal stenosis. There were no indications for surgical intervention. Neurology was consulted and affirmed that the MRI findings were consistent with his underlying chronic conditions. They recommended diastat for a seizure rescue medication at home and an outpatient neurology follow up.   After being extubated on 11/5, Patient was advanced to a regular diet which he tolerated well.    Patient was admitted to the general pediatrics from 11/6-11/7.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Had a skin reaction to the original vaccine; Started experiencing red dots on her legs; This spontaneous case was reported by a patient and describes the occurrence of SKIN REACTION (Had a skin reaction to the original vaccine) and RASH MACULAR (Started experiencing red dots on her legs) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Patient not ever had COVID positive test or diagnosis.  The patient's past medical history included Mosquito bite (Reactions like this with mosquito bites since she was 5 years old). Concurrent medical conditions included Glaucoma, Shellfish allergy, Herbal allergy (sage), Spice allergy (Sumac) and Allergy to chemicals (Preservatives).    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On an unknown date, the patient experienced SKIN REACTION (Had a skin reaction to the original vaccine) and RASH MACULAR (Started experiencing red dots on her legs). At the time of the report, SKIN REACTION (Had a skin reaction to the original vaccine) and RASH MACULAR (Started experiencing red dots on her legs) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medication include Eye drops which was used for Glaucoma.  No other vaccines was given within 1 month prior to Moderna COVID-19 vaccine.  It was reported that patient did not visit doctor so she took telemedicine appointment approximately 1-1 and a half week after she had reaction.  No treatment drug details was reported.   This case was linked to MOD-2022-670154, MOD-2022-670153 (Patient Link).
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash macular, Skin reaction
Clinical narrative: Had a skin reaction to the original vaccine; Started experiencing red dots on her legs; This spontaneous case was reported by a patient and describes the occurrence of SKIN REACTION (Had a skin reaction to the original vaccine) and RASH MACULAR (Started experiencing red dots on her legs) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Patient not ever had COVID positive test or diagnosis.  The patient's past medical history included Mosquito bite (Reactions like this with mosquito bites since she was 5 years old). Concurrent medical conditions included Glaucoma, Shellfish allergy, Herbal allergy (sage), Spice allergy (Sumac) and Allergy to chemicals (Preservatives).    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On an unknown date, the patient experienced SKIN REACTION (Had a skin reaction to the original vaccine) and RASH MACULAR (Started experiencing red dots on her legs). At the time of the report, SKIN REACTION (Had a skin reaction to the original vaccine) and RASH MACULAR (Started experiencing red dots on her legs) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medication include Eye drops which was used for Glaucoma.  No other vaccines was given within 1 month prior to Moderna COVID-19 vaccine.  It was reported that patient did not visit doctor so she took telemedicine appointment approximately 1-1 and a half week after she had reaction.  No treatment drug details was reported.   This case was linked to MOD-2022-670154, MOD-2022-670153 (Patient Link).
Sex: U
Vaccine: PPV
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event; Inbound call from HCP stating PNEUMOVAX 23 was inadvertently administered after it's expiration date.  No symptomatic side effects reported. No additional AE details or PQC.; This spontaneous report was received from a registered pharmacist and referred to an unknown age and gender patient. Pertinent medical history, concomitant medications and drug reactions/allergies were not reported.  On 29-OCT-2022, the patient started was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, lot #T039322, expiration date: 09-SEP-2022 for prophylaxis (strength, dose and route of administration were not provided) after expiration date (expired product administered). No symptomatic side effects were reported (no adverse event).
Sex: F
Vaccine: HPV4
Symptoms: Facial paralysis, Food allergy, Incomplete course of vaccination, Monoplegia, Paraesthesia
Clinical narrative: within 24 hours of the GARDASIL injection, she had paralysis of her left arm and the left side of her face; within 24 hours of the GARDASIL injection, she had paralysis of her left arm and the left side of her face; they were unable to determine the cause of the paralysis but thought it may be related to allergies/it was discovered that the daughter had multiple food allergies; she still has some tingling in her hands; This spontaneous report has been received from a Nurse Practitioner (N.P.) (also reported as HCP) via company representative, and refers to her daughter, a female patient of unspecified age. Her pertinent medical history, concurrent conditions, past drug reactions or allergies and concomitant medications were unknown by the reporter.  In approximately 2011 (reported as approximately 11 years ago), when patient was in college, she was administered the first dose in the series of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) intramuscular injection (strength, dosage, vaccination scheme frequency, route of administration, anatomical site of application, lot number and expiration date were unknown by the reporter) as prophylaxis. Then, whitin twenty-four (24) hours of the vaccine, she had paralysis of her left arm (monoplegia) and the left side of her face (facial paralysis).   On an unspecified date, the patient was hospitalized due to the events and treated at hospital for four to five (4-5) weeks, after the hospital discharged, she had months of physical therapy. It was reported that she had made almost a full recovery, but she still had some tingling in her hands (paraesthesia). Additionally, it was discovered that the patient had multiple food allergies (food allergy).  It was unknown by the reporter if any lab diagnostics or studies were performed. Also, it was stated that the reporter had another daughter who received the complete quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) series without any issues.  The outcome of the monoplegia and facial paralysis events was assessed as recovering, for the paraesthesia event it was assessed as not recovered, and regarding the food allergy event it was unknown. The action taken with the suspect vaccine was withdrawn since due to the monoplegia and facial paralysis events the series was not completed, for the rest of the events it was assessed as not applicable.  The causality assessment between the monoplegia and facial paralysis events with the suspect vaccine was unknown since it was stated that it was unable to determine the cause of the paralysis but thought it may be related to allergies, further explained as multiple food allergies; regarding the rest of the events information was not provided.  Upon internal review, monoplegia and facial paralysis events were determined to be medically significant.
Sex: M
Vaccine: TYP
Symptoms: Body temperature increased, COVID-19
Clinical narrative: Covid; A spontaneous report was received from a nurse on 19OCT2022 along with additional information received on 20OCT2022 and 21OCT2022. It described a 61-year-old male patient who was diagnosed with Covid (PT: COVID-19) following administration of oral Vivotif capsule (typhoid vaccine live oral Ty21A) (lot number: 3003783, expiry date: 31AUG2023; National drug code (NDC): 69401-000-01) for immunisation. It was reported that on 15OCT2022 (Saturday), the patient took the first dose of Vivotif following which he was admitted to an emergency room due to high temperature and was diagnosed with Covid. Reportedly, the patient was given Paxlovid as a treatment medication and was advised to discontinue taking Vivotif. It was confirmed that on the same day (15OCT2022) the patient was back at his home. Furthermore, it was reported that the patient was left with one pill of Paxlovid, the next dose of which would be on 20OCT2022. Additionally, the reporter confirmed that the patient was fine and just congested and again wanted to start taking Vivotif.  The patient was recovering from the reported event, at the time of this report. Therapy with Vivotif was withdrawn with respect to the reported event.  The patient had no medical history, or allergies and was not on any concomitant medications.  No additional information was reported.  Company comment: It was reported that a patient took the first dose of Vivotif for immunisation and was diagnosed with Covid (COVID-19). In response to the event, he took Paxlovid and Vivotif was discontinued. Further information regarding the event, medical history and concomitant medication is limited. Considering the limited case information, the causality of COVID-19 is assessed as possible with Vivotif. The case is considered non-serious as per medical assessment.; Sender's Comments: It was reported that a patient took the first dose of Vivotif for immunisation and was diagnosed with Covid (COVID-19). In response to the event, he took Paxlovid and Vivotif was discontinued. Further information regarding the event, medical history and concomitant medication is limited. Considering the limited case information, the causality of COVID-19 is assessed as possible with Vivotif. The case is considered non-serious as per medical assessment.
Sex: F
Vaccine: TYP
Symptoms: Pruritus, Urticaria
Clinical narrative: Some itchiness on her torso/ More itchiness in her abdomen area and it expanded in night; Hives; A spontaneous report was received from a physician's assistant and the patient on 25OCT2022.   A 41-years-old female patient who had "hives" (PT: Urticaria) and "some itchiness on her torso/ more itchiness in her abdomen area and it expanded in night" (PT: Pruritus) following administration of Vivotif (Typhoid vaccine live oral Ty21A) (lot number: unknown) for immunisation.   On 22OCT2022, the patient received the first dose of Vivotif, followed by the second dose on 24OCT2022 at 7 AM. It was reported that the patient had hives within four hours of the second dose of Vivotif. Reportedly, following the second dose; on the same day, at about 1 in the afternoon, the patient noticed some itchiness on her torso, and later at about 8 PM, she noticed more itchiness in her mid abdomen and leg area which expanded at night. Additionally, it was reported that the patient was given Zyrtec (anti histamine) and hydrocortisone cream to counter the effect of the events.  The patient had not recovered from the reported events, at the time of this report.  Action taken with Vivotif with respect to the reported events was unknown.  The patient had allergic reactions to Keflex and Cephalexin (rashes, itchiness) and had a seasonal allergy to grass and trees mostly in spring (June-July). The patient had undergone laparoscopic surgery of the uterus and caesarean section (C-section). Reportedly, the patient had three babies, she retained her placenta, and had to have it surgically removed.  Concomitant medications included iodine and progesterone.  No additional information was reported.  Company comment: It was reported that a patient took second dose of Vivotif and developed hives (urticaria) and some itchiness on her torso/ more itchiness in her abdomen area and it expanded in night (pruritus). Further information regarding the events is limited. Considering the case information, the role of Vivotif cannot be ruled out, and the causality of urticaria and pruritus is assessed as possible. The case is considered non serious as per medical assessment.; Sender's Comments: It was reported that a patient took second dose of Vivotif and developed hives (urticaria) and some itchiness on her torso/ more itchiness in her abdomen area and it expanded in night (pruritus). Further information regarding the events is limited. Considering the case information, the role of Vivotif cannot be ruled out, and the causality of urticaria and pruritus is assessed as possible. The case is considered non serious as per medical assessment.